Lloyd Diamond, Chief Executive Officer (CEO)

Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.

Didier Laurens, Chief Financial Officer (CFO)

Didier brings extensive finance and capital markets experience, most recently as Director Investor Relations, Financing and Treasury at Korian, where he also served as Interim CFO. Previously, he was Financial Analyst with Société Générale covering various sectors including healthcare, where he accompanied numerous IPO’s. He also served as Marketing Manager in the pharmaceutical industry. Didier holds a post-graduate of Pharmacy, and is graduated from SFAF/CIIA.

Karine Chevrie, Phd, Regulatory Affairs and Quality Director

Karine Chevrie has a PhD in Biochemistry and 20 years’ experience in the field of medical devices. During her career, she was notably in charge of regulatory strategies which contributed to obtaining CE marks and FDA approvals. She also built and managed quality management systems complying to ISO 13485 and 21CFR820 US regulation. From 2006 to 2015, Karine Chevrie held the position of Regulatory Affairs and Quality Director at EOS Imaging. Previously, she was for 7 years in charge of medical devices that hold a biological risk at AFSSAPS (now ANSM). In that framework, she participated in several work groups at the European Commission.

Guillaume Buc, Chief Technology Officer (CTO)

Guillaume Buc has over 25 years’ experience in technology development. Before joining Pixium Vision, Mr. Buc held several management positions at GE Healthcare Europe. His latest role was CTO of the GEHC interventional cardiology department. He received an engineering degree from the French Polytechnic Institute, in applied mathematics, and a degree from the Ecole Nationale Supérieure des Télécommunications / National Telecommunications School in Paris, in image processing and computer sciences.

Ralf Hornig, Phd, Director Clinical Affairs

Dr. Ralf Hornig has more than 20 years of experience in Retinal Implant research and Artificial Vision. He received a degree in electrical engineering from the University of Hanover, Germany in 1995 and the PhD degree with highest honor in 2001 at the Technical University of Berlin, Germany. Between 1996 and 2001 his research activities included system tests, computer simulations, ASIC development as well as pre-clinical test for retina implants at the University of Bonn, Germany. From 2001 to 2012 he was member of the management team at  Intelligent Medical Implants (IMI), where he was responsible for pre-clinical and clinical trials. He remains a scientific peer reviewer for international publications.